Suivre
Abonner curasan AG

curasan AG

Filtre
  • 11.06.2008 – 08:25

    euro adhoc: Earnings Forecast / curasan AG: Profit forecast following sale of dental division

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.06.2008 Kleinostheim, June 11, 2008 - Curasan AG (ISIN: DE 000 549 453 8), listed in the Prime Standard, has sold its dental division to Riemser Arzneimittel AG, Greifswald, effective from July 1, 2008. The earnings expected therefrom will ...

  • 12.03.2008 – 08:26

    euro adhoc: curasan AG / other / curasan AG: New Products for Oral Surgery

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. New Products 12.03.2008 curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard signed a distributorship agreement with Osteogenics Biomedical Inc., Lubbock, Texas, USA. Thereby, curasan is granted the distribution rights for a powerful ...

  • 14.06.2007 – 14:33

    euro adhoc: curasan AG / Director's Dealings

    Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 14.06.2007 Xetra (euro adhoc) - Details of the person subject to the disclosure requirement: Name: Hans Dieter Rössler Name of ...

  • 14.06.2007 – 09:27

    curasan AG: REVOIS® All-in-One Dental Implant System Registered in the U.S.

    ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. new product Kleinostheim (euro adhoc) - curasan AG, a German leader in regenerative medicine, has obtained FDA clearance for its REVOIS® All-in-One dental implant system, permitting the sale of the system in the U.S. This means that the system can be ...